Answers are grounded in this paper and cite their sources.
Demonstrates anticancer activity in colorectal cancer, suggesting a new therapeutic strategy.
cell cycle arrest, and improved cellular uptake compared to control group. The current investigation suggests that QbD-engineered zein-chitosan-based-NX could be a promising therapeutic strategy for managing CRC.
No takes yet. Share an insight, caveat, or question.
Gomte et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: